CDRH develops draft guidance for two device-exemption types

08/20/2008 | FDAnews

The FDA's Center for Devices and Radiological Health has released a draft guidance aimed at helping researchers, institutional review boards and device-trial sponsors distinguish between humanitarian device exemptions and investigational device exemptions. With an HDE, manufacturers are not required to provide a reasonable proof of effectiveness. An exemption for an IDE indicates that some rules do not have to be followed to perform a clinical study of an unapproved product, according to the guidance.

View Full Article in:

FDAnews

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Claims Director
PacificSource
Springfield, OR
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA